Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Genetic Variation Underpinning ADHD Risk in a Caribbean Community.

Puentes-Rozo PJ, Acosta-López JE, Cervantes-Henríquez ML, Martínez-Banfi ML, Mejia-Segura E, Sánchez-Rojas M, Anaya-Romero ME, Acosta-Hoyos A, García-Llinás GA, Mastronardi CA, Pineda DA, Castellanos FX, Arcos-Burgos M, Vélez JI.

Cells. 2019 Aug 16;8(8). pii: E907. doi: 10.3390/cells8080907.

2.

Experimental Models of Glaucoma: A Powerful Translational Tool for the Future Development of New Therapies for Glaucoma in Humans-A Review of the Literature.

Evangelho K, Mastronardi CA, de-la-Torre A.

Medicina (Kaunas). 2019 Jun 17;55(6). pii: E280. doi: 10.3390/medicina55060280. Review.

3.

Congenital Leptin Deficiency and Leptin Gene Missense Mutation Found in Two Colombian Sisters with Severe Obesity.

Yupanqui-Lozno H, Bastarrachea RA, Yupanqui-Velazco ME, Alvarez-Jaramillo M, Medina-Méndez E, Giraldo-Peña AP, Arias-Serrano A, Torres-Forero C, Garcia-Ordoñez AM, Mastronardi CA, Restrepo CM, Rodriguez-Ayala E, Nava-Gonzalez EJ, Arcos-Burgos M, Kent JW Jr, Cole SA, Licinio J, Celis-Regalado LG.

Genes (Basel). 2019 May 7;10(5). pii: E342. doi: 10.3390/genes10050342.

4.

Generation of one iPSC line (IMEDEAi006-A) from an early-onset familial Alzheimer's Disease (fAD) patient carrying the E280A mutation in the PSEN1 gene.

Vallejo-Diez S, Fleischer A, Martín-Fernández JM, Sánchez-Gilabert A, Castresana M, Aguillón D, Villegas A, Mastronardi CA, Espinosa LG, Arcos-Burgos M, Del Pozo Á, Herrán E, Gainza E, Isaza-Ruget M, Lopera F, Bachiller D.

Stem Cell Res. 2019 May;37:101440. doi: 10.1016/j.scr.2019.101440. Epub 2019 Apr 15.

5.

ADGRL3 (LPHN3) variants predict substance use disorder.

Arcos-Burgos M, Vélez JI, Martinez AF, Ribasés M, Ramos-Quiroga JA, Sánchez-Mora C, Richarte V, Roncero C, Cormand B, Fernández-Castillo N, Casas M, Lopera F, Pineda DA, Palacio JD, Acosta-López JE, Cervantes-Henriquez ML, Sánchez-Rojas MG, Puentes-Rozo PJ, Molina BSG; MTA Cooperative Group, Boden MT, Wallis D, Lidbury B, Newman S, Easteal S, Swanson J, Patel H, Volkow N, Acosta MT, Castellanos FX, de Leon J, Mastronardi CA, Muenke M.

Transl Psychiatry. 2019 Jan 29;9(1):42. doi: 10.1038/s41398-019-0396-7.

6.

Short-term antidepressant treatment has long-lasting effects, and reverses stress-induced decreases in bone features in rats.

Lee SH, Mastronardi CA, Li RW, Paz-Filho G, Dutcher EG, Lewis MD, Vincent AD, Smith PN, Bornstein SR, Licinio J, Wong ML.

Transl Psychiatry. 2019 Jan 16;9(1):10. doi: 10.1038/s41398-018-0351-z.

7.

Neuroimmunomodulation in Major Depressive Disorder: Focus on Caspase 1, Inducible Nitric Oxide Synthase, and Interferon-Gamma.

Inserra A, Mastronardi CA, Rogers G, Licinio J, Wong ML.

Mol Neurobiol. 2019 Jun;56(6):4288-4305. doi: 10.1007/s12035-018-1359-3. Epub 2018 Oct 10. Review.

8.

Leptin: role over central nervous system in epilepsy.

Mora-Muñoz L, Guerrero-Naranjo A, Rodríguez-Jimenez EA, Mastronardi CA, Velez-van-Meerbeke A.

BMC Neurosci. 2018 Sep 5;19(1):51. doi: 10.1186/s12868-018-0453-9.

9.

Targeting Neuroplasticity, Cardiovascular, and Cognitive-Associated Genomic Variants in Familial Alzheimer's Disease.

Vélez JI, Lopera F, Creagh PK, Piñeros LB, Das D, Cervantes-Henríquez ML, Acosta-López JE, Isaza-Ruget MA, Espinosa LG, Easteal S, Quintero GA, Silva CT, Mastronardi CA, Arcos-Burgos M.

Mol Neurobiol. 2019 May;56(5):3235-3243. doi: 10.1007/s12035-018-1298-z. Epub 2018 Aug 15.

10.

Mutations modifying sporadic Alzheimer's disease age of onset.

Vélez JI, Lopera F, Patel HR, Johar AS, Cai Y, Rivera D, Tobón C, Villegas A, Sepulveda-Falla D, Lehmann SG, Easteal S, Mastronardi CA, Arcos-Burgos M.

Am J Med Genet B Neuropsychiatr Genet. 2016 Dec;171(8):1116-1130. doi: 10.1002/ajmg.b.32493. Epub 2016 Aug 30.

PMID:
27573710
11.

Role of the IL-1 Pathway in Dopaminergic Neurodegeneration and Decreased Voluntary Movement.

Stojakovic A, Paz-Filho G, Arcos-Burgos M, Licinio J, Wong ML, Mastronardi CA.

Mol Neurobiol. 2017 Aug;54(6):4486-4495. doi: 10.1007/s12035-016-9988-x. Epub 2016 Jun 29.

12.

Neural Plasticity in Obesity and Psychiatric Disorders.

Arcos-Burgos M, Acosta MT, Martinez AF, Muenke M, Enriori PJ, Mastronardi CA.

Neural Plast. 2016;2016:6053871. doi: 10.1155/2016/6053871. Epub 2016 Apr 7. No abstract available.

13.

Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition.

Wong ML, Inserra A, Lewis MD, Mastronardi CA, Leong L, Choo J, Kentish S, Xie P, Morrison M, Wesselingh SL, Rogers GB, Licinio J.

Mol Psychiatry. 2016 Jun;21(6):797-805. doi: 10.1038/mp.2016.46. Epub 2016 Apr 19.

14.

A Mutation in DAOA Modifies the Age of Onset in PSEN1 E280A Alzheimer's Disease.

Vélez JI, Rivera D, Mastronardi CA, Patel HR, Tobón C, Villegas A, Cai Y, Easteal S, Lopera F, Arcos-Burgos M.

Neural Plast. 2016;2016:9760314. doi: 10.1155/2016/9760314. Epub 2016 Jan 5.

15.

Association between circulating adipocytokine concentrations and microvascular complications in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of controlled cross-sectional studies.

Rodríguez AJ, Nunes Vdos S, Mastronardi CA, Neeman T, Paz-Filho GJ.

J Diabetes Complications. 2016 Mar;30(2):357-67. doi: 10.1016/j.jdiacomp.2015.11.004. Epub 2015 Nov 7. Review.

16.

APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer's disease.

Vélez JI, Lopera F, Sepulveda-Falla D, Patel HR, Johar AS, Chuah A, Tobón C, Rivera D, Villegas A, Cai Y, Peng K, Arkell R, Castellanos FX, Andrews SJ, Silva Lara MF, Creagh PK, Easteal S, de Leon J, Wong ML, Licinio J, Mastronardi CA, Arcos-Burgos M.

Mol Psychiatry. 2016 Jul;21(7):916-24. doi: 10.1038/mp.2015.177. Epub 2015 Dec 1.

17.

Linkage and association analysis of ADHD endophenotypes in extended and multigenerational pedigrees from a genetic isolate.

Mastronardi CA, Pillai E, Pineda DA, Martinez AF, Lopera F, Velez JI, Palacio JD, Patel H, Easteal S, Acosta MT, Castellanos FX, Muenke M, Arcos-Burgos M.

Mol Psychiatry. 2016 Oct;21(10):1434-40. doi: 10.1038/mp.2015.172. Epub 2015 Nov 24.

18.

New advances in the treatment of generalized lipodystrophy: role of metreleptin.

Rodriguez AJ, Mastronardi CA, Paz-Filho GJ.

Ther Clin Risk Manag. 2015 Sep 16;11:1391-400. doi: 10.2147/TCRM.S66521. eCollection 2015. Review.

19.

Periodontal Disease and Its Systemic Associated Diseases.

Fernandez-Solari J, Barrionuevo P, Mastronardi CA.

Mediators Inflamm. 2015;2015:153074. doi: 10.1155/2015/153074. Epub 2015 Aug 4. No abstract available.

20.

The use of dried blood spot sampling for the measurement of HbA1c: a cross-sectional study.

Mastronardi CA, Whittle B, Tunningley R, Neeman T, Paz-Filho G.

BMC Clin Pathol. 2015 Jul 8;15:13. doi: 10.1186/s12907-015-0013-5. eCollection 2015.

21.

Temporal gene expression in the hippocampus and peripheral organs to endotoxin-induced systemic inflammatory response in caspase-1-deficient mice.

Mastronardi CA, Paz-Filho G, Zanoni M, Molano-González N, Arcos-Burgos M, Licinio J, Wong ML.

Neuroimmunomodulation. 2015;22(4):263-73. doi: 10.1159/000368310. Epub 2015 Jan 24.

22.

Leptin replacement therapy for the treatment of non-HAART associated lipodystrophy syndromes: a meta-analysis into the effects of leptin on metabolic and hepatic endpoints.

Rodríguez AJ, Neeman T, Giles AG, Mastronardi CA, Paz Filho G.

Arq Bras Endocrinol Metabol. 2014 Nov;58(8):783-97. Epub 2014 Nov 1. Review.

PMID:
25465598
23.

Whole exome sequencing of extreme morbid obesity patients: translational implications for obesity and related disorders.

Paz-Filho G, Boguszewski MC, Mastronardi CA, Patel HR, Johar AS, Chuah A, Huttley GA, Boguszewski CL, Wong ML, Arcos-Burgos M, Licinio J.

Genes (Basel). 2014 Aug 25;5(3):709-25. doi: 10.3390/genes5030709.

24.

Leptin treatment: facts and expectations.

Paz-Filho G, Mastronardi CA, Licinio J.

Metabolism. 2015 Jan;64(1):146-56. doi: 10.1016/j.metabol.2014.07.014. Epub 2014 Aug 3. Review.

25.

Molecular pathways involved in the improvement of non-alcoholic fatty liver disease.

Paz-Filho G, Mastronardi CA, Parker BJ, Khan A, Inserra A, Matthaei KI, Ehrhart-Bornstein M, Bornstein S, Wong ML, Licinio J.

J Mol Endocrinol. 2013 Jun 29;51(1):167-79. doi: 10.1530/JME-13-0072. Print 2013.

PMID:
23718963
26.

Candidate biomarkers for systemic inflammatory response syndrome and inflammation: a pathway for novel translational therapeutics.

Mastronardi CA, Licinio J, Wong ML.

Neuroimmunomodulation. 2010;17(6):359-68. doi: 10.1159/000292040. Epub 2010 May 29.

PMID:
20516717
27.

Repeated antidepressant therapy increases cyclic GMP signaling in rat hippocampus.

Reierson GW, Mastronardi CA, Licinio J, Wong ML.

Neurosci Lett. 2009 Dec 11;466(3):149-53. doi: 10.1016/j.neulet.2009.09.047. Epub 2009 Sep 27.

28.

Chronic imipramine downregulates cyclic AMP signaling in rat hippocampus.

Reierson GW, Mastronardi CA, Licinio J, Wong ML.

Neuroreport. 2009 Feb 18;20(3):307-11.

PMID:
19444954
29.

Chronic fluoxetine treatment increases daytime melatonin synthesis in the rodent.

Reierson GW, Mastronardi CA, Licinio J, Wong ML.

Clin Pharmacol. 2009;1:1-6. doi: 10.2147/CPAA.S7157. Epub 2009 Sep 7.

30.

Lipopolysaccharide-induced leptin synthesis and release are differentially controlled by alpha-melanocyte-stimulating hormone.

Mastronardi CA, Srivastava V, Yu WH, Dees WL, McCann SM.

Neuroimmunomodulation. 2005;12(3):182-8.

PMID:
15905627
31.

Inhibition of melatonin-induced ascorbic acid and LHRH release by a nitric oxide synthase and cyclic GMP inhibitor.

Karanth S, Yu WH, Mastronardi CA, McCann SM.

Exp Biol Med (Maywood). 2004 Jul;229(7):650-6.

PMID:
15229359
32.
33.

Vitamin E stimulates luteinizing hormone-releasing hormone and ascorbic acid release from medial basal hypothalami of adult male rats.

Karanth S, Yu WH, Mastronardi CA, McCann SM.

Exp Biol Med (Maywood). 2003 Jul;228(7):779-85.

PMID:
12876296
34.

Hypothalamic control of gonadotropin secretion.

McCann SM, Karanth S, Mastronardi CA, Dees WL, Childs G, Miller B, Sower S, Yu WH.

Prog Brain Res. 2002;141:151-64. Review. No abstract available.

PMID:
12508567
35.

Lamprey GnRH-III acts on its putative receptor via nitric oxide to release follicle-stimulating hormone specifically.

Yu WH, Karanth S, Mastronardi CA, Sealfon S, Dean C, Dees WL, McCann SM.

Exp Biol Med (Maywood). 2002 Oct;227(9):786-93.

PMID:
12324658
36.

Resting and circadian release of nitric oxide is controlled by leptin in male rats.

Mastronardi CA, Yu WH, McCann SM.

Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5721-6.

37.

Lipopolysaccharide-induced tumor necrosis factor-alpha release is controlled by the central nervous system.

Mastronardi CA, Yu WH, McCann S.

Neuroimmunomodulation. 2001;9(3):148-56.

PMID:
11752888
38.

Control of gonadotropin secretion by follicle-stimulating hormone-releasing factor, luteinizing hormone-releasing hormone, and leptin.

McCann SM, Karanth S, Mastronardi CA, Dees WL, Childs G, Miller B, Sower S, Yu WH.

Arch Med Res. 2001 Nov-Dec;32(6):476-85. Review.

PMID:
11750723
39.

Lipopolysaccharide-induced leptin release is neurally controlled.

Mastronardi CA, Yu WH, Srivastava VK, Dees WL, McCann SM.

Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14720-5. Epub 2001 Nov 27.

40.

Ascorbic acid stimulates gonadotropin release by autocrine action by means of NO.

Karanth S, Yu WH, Walczewska A, Mastronardi CA, McCann SM.

Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11783-8. Epub 2001 Sep 18.

41.
42.

Cytokines and pituitary hormone secretion.

McCann SM, Kimura M, Yu WH, Mastronardi CA, Rettori V, Karanth S.

Vitam Horm. 2001;63:29-62. Review. No abstract available.

PMID:
11358117
43.

The mechanism of action of cytokines to control the release of hypothalamic and pituitary hormones in infection.

McCann SM, Kimura M, Karanth S, Yu WH, Mastronardi CA, Rettori V.

Ann N Y Acad Sci. 2000;917:4-18. Review.

PMID:
11268367
44.

Lipopolysaccharide-induced leptin release is not mediated by nitric oxide, but is blocked by dexamethasone.

Mastronardi CA, Yu WH, Rettori V, McCann S.

Neuroimmunomodulation. 2000;8(2):91-7.

PMID:
10965234
45.

The possible role of prolactin in the circadian rhythm of leptin secretion in male rats.

Mastronardi CA, Walczewska A, Yu WH, Karanth S, Parlow AF, McCann SM.

Proc Soc Exp Biol Med. 2000 Jul;224(3):152-8.

PMID:
10865230
46.

Inhibitory pathways and the inhibition of luteinizing hormone-releasing hormone release by alcohol.

Lomniczi A, Mastronardi CA, Faletti AG, Seilicovich A, De Laurentiis A, McCann SM, Rettori V.

Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2337-42.

47.

beta-Endorphin blocks luteinizing hormone-releasing hormone release by inhibiting the nitricoxidergic pathway controlling its release.

Faletti AG, Mastronardi CA, Lomniczi A, Seilicovich A, Gimeno M, McCann SM, Rettori V.

Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1722-6.

48.

Role of nitric oxide in salivary secretion.

Lomniczi A, Suburo AM, Elverdin JC, Mastronardi CA, Diaz S, Rettori V, McCann SM.

Neuroimmunomodulation. 1998 Sep-Oct;5(5):226-33.

PMID:
9730690

Supplemental Content

Loading ...
Support Center